RN7SL230P

Across TCGA pan-cancer cohorts, RN7SL230P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RN7SL230P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RN7SL230P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL230P expression acts as an unfavorable survival marker, although some lineages such as LUAD and CESC show a favorable association.

LUAD, READ, and CESC are the cancer types where RN7SL230P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	III,IV	0.570	0.283	.013	27	view →
READ	DFS	Quartile	III,IV	0.464	0.795	.002	27	view →
CESC	DFS	Median	II,III,IV	0.818	0.642	.027	26	view →
HNSC	DFS	Tertile	III,IV	0.581	0.696	.013	24	view →
SKCM	OS	Tertile	III,IV	0.633	0.321	.013	18	view →
KIRC	DFS	Tertile	IV	0.345	0.674	.005	16	view →
LIHC	OS	Tertile	III,IV	0.743	0.246	.011	15	view →
UCEC	DFS	Tertile	All	0.769	0.856	.015	12	view →
ACC	OS	Tertile	All	0.649	0.914	.027	12	view →
CHOL	DFS	Tertile	All	0.120	0.536	.018	9	view →
PRAD	DFS	Tertile	All	0.880	0.736	.036	8	view →
PAAD	DFS	Quartile	II,III,IV	0.323	0.448	.034	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RN7SL230P–LUAD (DFS)

Open the LUAD breakdown →